Literature DB >> 18334108

[Cancer incidence and mortality in Guangzhou City from 2000 to 2002].

Ka-Jia Cao1, Qiao-Yang Fan, Yi-Long Liu, Rong Huang, Chuan-Zhong Yin, Guo-Sheng Ma, Zi-Qun Liu, De-Sen Wan, Yi-Xin Zeng.   

Abstract

BACKGROUND &
OBJECTIVE: Population-based cancer registration has never been carried out before in Guangzhou. This study was to analyze the cancer incidence and mortality in Guangzhou and to provide references for prevention and treatment of cancer.
METHODS: Data of cancer incidence and mortality during 2000--2002 were collected from Guangzhou Population-based Cancer Registry. Cancer incidence and mortality were calculated and analyzed.
RESULTS: The crude cancer incidence during 2000--2002 in Guangzhou was 227.7 per 100,000 (257.0 per 100,000 in males and 196.5 per 100,000 in females)û the crude cancer mortality was 147.9 per 100,000 (183.6 per 100,000 in males and 109.7 per 100,000 in females). The incidence of lung cancer ranked first followed by those of liver cancer, nasopharyngeal cancer, gastric cancer and colon cancer in males. Breast cancer was the leading cancer in females followed by those of lung cancer, liver cancer, colon cancer and nasopharyngeal cancer. The cancer incidence and mortality increased with age.
CONCLUSION: Cancer incidence is high in Guangzhou, and the research for prevention and treatment of cancer should be enhanced.

Entities:  

Mesh:

Year:  2008        PMID: 18334108

Source DB:  PubMed          Journal:  Ai Zheng


  6 in total

1.  Impact of body mass index on survival of esophageal squamous carcinoma patients in southern China.

Authors:  Chao Ren; Xiu-Yu Cai; Miao-Zhen Qiu; De-Shen Wang; Feng-Hua Wang; Hui-Yan Luo; Rui-Hua Xu
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.

Authors:  Benqiang Rao; Yuanhong Gao; Qixu Zhou; Pei Xiao; Shuang Xia; Jingsheng Ma; Juan Luo; Tao Xiao; Shilian Le; Meijin Huang; Jianping Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-15       Impact factor: 4.553

3.  Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway.

Authors:  Jian-zhen Shan; Yan-yan Xuan; Shu Zheng; Qi Dong; Su-zhan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2009-09       Impact factor: 3.066

4.  NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population.

Authors:  Shunxin Song; Dianke Chen; Jiachun Lu; Jiawei Liao; Yanxin Luo; Zuli Yang; Xinhui Fu; Xinjuan Fan; Yisheng Wei; Lei Yang; Lei Wang; Jianping Wang
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

5.  The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer.

Authors:  Hong Chu-Yuan; Peng Jing; Wei Yi-Sheng; Peng He-Ping; Yang Hui; Zhao Chu-Xiong; Liang Guo-Jian; Wang Guo-Qiang
Journal:  BMC Cancer       Date:  2013-04-03       Impact factor: 4.430

6.  Smoking and nasopharyngeal carcinoma mortality: a cohort study of 101,823 adults in Guangzhou, China.

Authors:  Jia-Huang Lin; Chao-Qiang Jiang; Sai-Yin Ho; Wei-Sen Zhang; Zhi-Ming Mai; Lin Xu; Ching-Man Lo; Tai-Hing Lam
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.